137 related articles for article (PubMed ID: 15761256)
1. Adenovirus-based genetic vaccines for biodefense.
Boyer JL; Kobinger G; Wilson JM; Crystal RG
Hum Gene Ther; 2005 Feb; 16(2):157-68. PubMed ID: 15761256
[TBL] [Abstract][Full Text] [Related]
2. Adenovirus vector-based vaccines for human immunodeficiency virus type 1.
Barouch DH; Nabel GJ
Hum Gene Ther; 2005 Feb; 16(2):149-56. PubMed ID: 15761255
[TBL] [Abstract][Full Text] [Related]
3. Short communication: enhancement of immunogenicity of replication-defective adenovirus-based human immunodeficiency virus vaccines in rhesus monkeys.
Sun C; Zhang Y; Liu Y; Zhang M; Chen L
AIDS Res Hum Retroviruses; 2011 Jun; 27(6):681-6. PubMed ID: 21083437
[TBL] [Abstract][Full Text] [Related]
4. Adenoviruses as vectors for HIV vaccines.
Gómez-Román VR; Robert-Guroff M
AIDS Rev; 2003; 5(3):178-85. PubMed ID: 14598567
[TBL] [Abstract][Full Text] [Related]
5. Characterization of immune responses induced by combined clade-A HIV-1 recombinant adenovectors in mice.
Bayanolhagh S; Alinezhad M; Kamali K; Foroughi M; Khorram Khorshid HR; Mohraz M; Mahboudi F; Pourfathollah AA
Iran J Immunol; 2010 Sep; 7(3):162-76. PubMed ID: 20876987
[TBL] [Abstract][Full Text] [Related]
6. Engineered adenovirus serotypes for overcoming anti-vector immunity.
Dharmapuri S; Peruzzi D; Aurisicchio L
Expert Opin Biol Ther; 2009 Oct; 9(10):1279-87. PubMed ID: 19645630
[TBL] [Abstract][Full Text] [Related]
7. Adenovirus vectors as HIV-1 vaccines: where are we? What next?
DʼSouza MP; Yang OO
AIDS; 2015 Feb; 29(4):395-400. PubMed ID: 25630039
[No Abstract] [Full Text] [Related]
8. A Partial E3 Deletion in Replication-Defective Adenoviral Vectors Allows for Stable Expression of Potentially Toxic Transgene Products.
Haut LH; Gill AL; Kurupati RK; Bian A; Li Y; Giles-Davis W; Xiang Z; Zhou XY; Ertl HC
Hum Gene Ther Methods; 2016 Oct; 27(5):187-196. PubMed ID: 27604324
[TBL] [Abstract][Full Text] [Related]
9. Potent specific immune responses induced by prime-boost-boost strategies based on DNA, adenovirus, and Sendai virus vectors expressing gag gene of Chinese HIV-1 subtype B.
Yu S; Feng X; Shu T; Matano T; Hasegawa M; Wang X; Ma H; Li H; Li Z; Zeng Y
Vaccine; 2008 Nov; 26(48):6124-31. PubMed ID: 18812199
[TBL] [Abstract][Full Text] [Related]
10. Insertion of HIV-1 genes into Ad4DeltaE3 vector abrogates increased pathogenesis in cotton rats due to E3 deletion.
Patterson LJ; Prince GA; Richardson E; Alvord WG; Kalyan N; Robert-Guroff M
Virology; 2002 Jan; 292(1):107-13. PubMed ID: 11878913
[TBL] [Abstract][Full Text] [Related]
11. Recent advances in the development of HIV-1 vaccines using replication-incompetent adenovirus vectors.
Shiver JW; Emini EA
Annu Rev Med; 2004; 55():355-72. PubMed ID: 14746526
[TBL] [Abstract][Full Text] [Related]
12. Prime-boost vaccination with plasmid DNA and a chimeric adenovirus type 5 vector with type 35 fiber induces protective immunity against HIV.
Xin KQ; Jounai N; Someya K; Honma K; Mizuguchi H; Naganawa S; Kitamura K; Hayakawa T; Saha S; Takeshita F; Okuda K; Honda M; Klinman DM; Okuda K
Gene Ther; 2005 Dec; 12(24):1769-77. PubMed ID: 16079886
[TBL] [Abstract][Full Text] [Related]
13. Delivery of antigens by viral vectors for vaccination.
Krause A; Worgall S
Ther Deliv; 2011 Jan; 2(1):51-70. PubMed ID: 22833925
[TBL] [Abstract][Full Text] [Related]
14. Adenoviral gene delivery for HIV-1 vaccination.
Vanniasinkam T; Ertl HC
Curr Gene Ther; 2005 Apr; 5(2):203-12. PubMed ID: 15853728
[TBL] [Abstract][Full Text] [Related]
15. A novel alphavirus replicon-vectored vaccine delivered by adenovirus induces sterile immunity against classical swine fever.
Sun Y; Li HY; Tian DY; Han QY; Zhang X; Li N; Qiu HJ
Vaccine; 2011 Oct; 29(46):8364-72. PubMed ID: 21888938
[TBL] [Abstract][Full Text] [Related]
16. Overcoming pre-existing adenovirus immunity by genetic engineering of adenovirus-based vectors.
Seregin SS; Amalfitano A
Expert Opin Biol Ther; 2009 Dec; 9(12):1521-31. PubMed ID: 19780714
[TBL] [Abstract][Full Text] [Related]
17. Targeted adenovirus vectors.
Mizuguchi H; Hayakawa T
Hum Gene Ther; 2004 Nov; 15(11):1034-44. PubMed ID: 15610604
[TBL] [Abstract][Full Text] [Related]
18. Isolation and characterization of packaging cell lines that coexpress the adenovirus E1, DNA polymerase, and preterminal proteins: implications for gene therapy.
Amalfitano A; Chamberlain JS
Gene Ther; 1997 Mar; 4(3):258-63. PubMed ID: 9135740
[TBL] [Abstract][Full Text] [Related]
19. Comparison between Sendai virus and adenovirus vectors to transduce HIV-1 genes into human dendritic cells.
Hosoya N; Miura T; Kawana-Tachikawa A; Koibuchi T; Shioda T; Odawara T; Nakamura T; Kitamura Y; Kano M; Kato A; Hasegawa M; Nagai Y; Iwamoto A
J Med Virol; 2008 Mar; 80(3):373-82. PubMed ID: 18205221
[TBL] [Abstract][Full Text] [Related]
20. Viral vectors as potential HIV-1 vaccines.
Schnell MJ
FEMS Microbiol Lett; 2001 Jun; 200(2):123-9. PubMed ID: 11425463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
